An assessment of progress in cancer control

CA Cancer Journal for Clinicians

Volumn 68, Issue 5, 2018, Pages 329-339

  Siegel, Rebecca L ^a   Jemal, Ahmedin ^a   Wender, Richard C ^a   Gansler, Ted ^a   Ma, Jiemin ^a   Brawley, Otis W ^a  

^a AMERICAN CANCER SOCIETY   (United States)

Author keywords

cancer control; cancer mortality; health disparities

Indexed keywords

ARTICLE; CANCER CONTROL; CANCER MORTALITY; CANCER PREVENTION; CANCER STAGING; HEALTH DISPARITY; HUMAN; NATIONAL HEALTH ORGANIZATION; NON PROFIT ORGANIZATION; VISION; ADOLESCENT; ADULT; AGED; BREAST TUMOR; CHILD; COLORECTAL TUMOR; EARLY CANCER DIAGNOSIS; EDUCATIONAL STATUS; FEMALE; HEALTH CARE DISPARITY; HEALTH CARE POLICY; LUNG TUMOR; MALE; MASS SCREENING; MIDDLE AGED; MORTALITY; NEOPLASM; SMOKING; UNITED STATES;

ADOLESCENT; ADULT; AGED; BREAST NEOPLASMS; CHILD; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; EDUCATIONAL STATUS; FEMALE; HEALTH STATUS DISPARITIES; HEALTHCARE DISPARITIES; HUMANS; LUNG NEOPLASMS; MALE; MASS SCREENING; MIDDLE AGED; NEOPLASMS; PATIENT PROTECTION AND AFFORDABLE CARE ACT; RACE FACTORS; SMOKING; UNITED STATES;

EID: 85054775165     PISSN: 00079235     EISSN: 15424863     Source Type: Journal    
DOI: 10.3322/caac.21460     Document Type: Article

References (69)

1. Taplin SH, Anhang Price R, Edwards HM, et al. Introduction: understanding and influencing multilevel factors across the cancer care continuum. J Natl Cancer Inst Monogr. 2012;2012:2-10
2. Cole P, Morrison AS. Basic issues in population screening for cancer. J Natl Cancer Inst. 1980;64:1263-1272
3. Croswell JM, Ransohoff DF, Kramer BS. Principles of cancer screening: lessons from history and study design issues. Semin Oncol. 2010;37:202-215
4. Cronin KA, Ries LA, Edwards BK. The Surveillance, Epidemiology, and End Results (SEER) program of the National Cancer Institute. Cancer. 2014;120(suppl 23):3755-3757
5. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64:9-29
6. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68:7-30
7. Sauer AG, Siegel RL, Jemal A, Fedewa SA. Updated review of prevalence of major risk factors and use of screening tests for cancer in the United States. Cancer Epidemiol Biomarkers Prev. 2017;26:1192-1208
8. Centers for Disease Control and Prevention (CDC). Tobacco use—United States, 1900-1999. MMWR Morb Mortal Wkly Rep. 1999;48:986-993
9. Jamal A, Phillips E, Gentzke AS, et al. Current cigarette smoking among adults—United States, 2016. MMWR Morb Mortal Wkly Rep. 2018;67:53-59
10. Drope J, Liber AC, Cahn Z, et al. Who's still smoking? Disparities in adult cigarette smoking prevalence in the United States. CA Cancer J Clin. 2018;68:106-115
11. Lortet-Tieulent J, Goding Sauer A, Siegel RL, et al. State-level cancer mortality attributable to cigarette smoking in the United States. JAMA Intern Med. 2016;176:1792-1798
12. Islami F, Goding Sauer A, Miller KD, et al. Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States. CA Cancer J Clin. 2018;68:31-54
13. Wingo PA, Cardinez CJ, Landis SH, et al. Long-term trends in cancer mortality in the United States, 1930-1998. Cancer. 2003;97:3133-3275
14. Noone AM, Howlader N, Krapcho M, et al, eds. SEER Cancer Statistics Review, 1975-2015. Bethesda, MD: National Cancer Institute; 2018. Available at: https://seer.cancer.gov/csr/1975_2015/. Accessed April 18, 2018
15. Walker TY, Elam-Evans LD, Singleton JA, et al. National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years—United States, 2016. MMWR Morb Mortal Wkly Rep. 2017;66:874-882
16. Islami F, Miller KD, Siegel RL, Fedewa SA, Ward EM, Jemal A. Disparities in liver cancer occurrence in the United States by race/ethnicity and state. CA Cancer J Clin. 2017;67:273-289
17. Welzel TM, Graubard BI, Quraishi S, et al. Population-attributable fractions of risk factors for hepatocellular carcinoma in the United States. Am J Gastroenterol. 2013;108:1314-1321
18. Tyson GL, El-Serag HB. Risk factors for cholangiocarcinoma. Hepatology. 2011;54:173-184
19. Sripa B, Kaewkes S, Sithithaworn P, et al. Liver fluke induces cholangiocarcinoma [serial online]. PLoS Med. 2007;4:e201
20. Eltom MA, Jemal A, Mbulaiteye SM, Devesa SS, Biggar RJ. Trends in Kaposi's sarcoma and non-Hodgkin's lymphoma incidence in the United States from 1973 through 1998. J Natl Cancer Inst. 2002;94:1204-1210
21. Howlader N, Shiels MS, Mariotto AB, Engels EA. Contributions of HIV to non-Hodgkin lymphoma mortality trends in the United States. Cancer Epidemiol Biomarkers Prev. 2016;25:1289-1296
22. Surveillance Research Program. DevCan: Probability of Developing or Dying of Cancer Software, Version 6.7.5. Bethesda, MD: Division of Cancer Control and Population Sciences, National Cancer Institute; 2012
23. Howlader N, Noone AM, Krapcho M, et al, eds. SEER Cancer Statistics Review, 1975-2014. Bethesda, MD: National Cancer Institute; 2017
24. Oeffinger KC, Tonorezos ES. The cancer is over, now what? Understanding risk, changing outcomes. Cancer. 2011;117:2250-2257
25. Oeffinger KC, Mertens AC, Sklar CA, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med. 2006;355:1572-1582
26. Shavers VL, Brown ML. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst. 2002;94:334-357
27. Brawley OW. Population categorization and cancer statistics. Cancer Metastasis Rev. 2003;22:11-19
28. Broder S. Progress and challenges in the National Cancer Program. In: Brugge J, Curran T, Harlow E, McCormick F, eds. Origins of Human Cancer: A Comprehensive Review. Plainview, NY: Cold Spring Harbor Laboratory Press; 1991:27-33
29. Winawer SJ. The history of colorectal cancer screening: a personal perspective. Dig Dis Sci. 2015;60:596-608
30. Daly B, Olopade OI. A perfect storm: how tumor biology, genomics, and health care delivery patterns collide to create a racial survival disparity in breast cancer and proposed interventions for change. CA Cancer J Clin. 2015;65:221-238
31. Wheeler SB, Reeder-Hayes KE, Carey LA. Disparities in breast cancer treatment and outcomes: biological, social, and health system determinants and opportunities for research. Oncologist. 2013;18:986-993
32. Bickell NA, Wang JJ, Oluwole S, et al. Missed opportunities: racial disparities in adjuvant breast cancer treatment. J Clin Oncol. 2006;24:1357-1362
33. Haggstrom DA, Quale C, Smith-Bindman R. Differences in the quality of breast cancer care among vulnerable populations. Cancer. 2005;104:2347-2358
34. Griggs JJ, Culakova E, Sorbero ME, et al. Effect of patient socioeconomic status and body mass index on the quality of breast cancer adjuvant chemotherapy. J Clin Oncol. 2007;25:277-284
35. DeSantis CE, Siegel RL, Sauer AG, et al. Cancer statistics for African Americans, 2016: progress and opportunities in reducing racial disparities. CA Cancer J Clin. 2016;66:290-308
36. Jemal A, Robbins AS, Lin CC, et al. Factors that contributed to black-white disparities in survival among nonelderly women with breast cancer between 2004 and 2013. J Clin Oncol. 2018;36:14-24
37. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67:7-30
38. Soni A, Sabik LM, Simon K, Sommers BD. Changes in insurance coverage among cancer patients under the Affordable Care Act. JAMA Oncol. 2018;4:122-124
39. DeSantis CE, Fedewa SA, Goding Sauer A, Kramer JL, Smith RA, Jemal A. Breast cancer statistics, 2015: convergence of incidence rates between black and white women. CA Cancer J Clin. 2016;66:31-42
40. Thomson CS, Hole DJ, Twelves CJ, Brewster DH, Black RJ. Prognostic factors in women with breast cancer: distribution by socioeconomic status and effect on differences in survival. J Epidemiol Community Health. 2001;55:308-315
41. Gordon NH. Association of education and income with estrogen receptor status in primary breast cancer. Am J Epidemiol. 1995;142:796-803
42. Fedewa SA, Flanders WD, Ward KC, et al. Racial and ethnic disparities in interval colorectal cancer incidence: a population-based cohort study. Ann Intern Med. 2017;166:857-866
43. Mandelblatt J, van Ravesteyn N, Schechter C, et al. Which strategies reduce breast cancer mortality most? Collaborative modeling of optimal screening, treatment, and obesity prevention. Cancer. 2013;119:2541-2548
44. Rhoads KF, Cullen J, Ngo JV, Wren SM. Racial and ethnic differences in lymph node examination after colon cancer resection do not completely explain disparities in mortality. Cancer. 2012;118:469-477
45. Fiscella K, Franks P, Gold MR, Clancy CM. Inequality in quality: addressing socioeconomic, racial, and ethnic disparities in health care. JAMA. 2000;283:2579-2584
46. Bach PB, Schrag D, Brawley OW, Galaznik A, Yakren S, Begg CB. Survival of blacks and whites after a cancer diagnosis. JAMA. 2002;287:2106-2113
47. Graham-Steed T, Uchio E, Wells CK, Aslan M, Ko J, Concato J. ‘Race’ and prostate cancer mortality in equal-access healthcare systems. Am J Med. 2013;126:1084-1088
48. Freedland SJ, Vidal AC, Howard LE, et al. Race and risk of metastases and survival after radical prostatectomy: results from the SEARCH database. Cancer. 2017;123:4199-4206
49. Moses KA, Paciorek AT, Penson DF, Carroll PR, Master VA. Impact of ethnicity on primary treatment choice and mortality in men with prostate cancer: data from CaPSURE. J Clin Oncol. 2010;28:1069-1074
50. Schwartz K, Powell IJ, Underwood W 3rd, George J, Yee C, Banerjee M. Interplay of race, socioeconomic status, and treatment on survival of patients with prostate cancer. Urology. 2009;74:1296-1302
51. Jayadevappa R, Chhatre S, Johnson JC, Malkowicz SB. Variation in quality of care among older men with localized prostate cancer. Cancer. 2011;117:2520-2529
52. Bhatia S. Disparities in cancer outcomes: lessons learned from children with cancer. Pediatr Blood Cancer. 2011;56:994-1002
53. Linabery AM, Ross JA. Childhood and adolescent cancer survival in the US by race and ethnicity for the diagnostic period 1975-1999. Cancer. 2008;113:2575-2596
54. Pui CH, Pei D, Pappo AS, et al. Treatment outcomes in black and white children with cancer: results from the SEER database and St Jude Children's Research Hospital, 1992 through 2007. J Clin Oncol. 2012;30:2005-2012
55. Surveillance, Epidemiology, and End Results (SEER) Program (seer.cancer.gov). SEER*Stat Database: Mortality–All COD, Aggregated With State, Total US (1969-2015) . Bethesda, MD: National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program; 2017
56. Naishadham D, Lansdorp-Vogelaar I, Siegel R, Cokkinides V, Jemal A. State disparities in colorectal cancer mortality patterns in the United States. Cancer Epidemiol Biomarkers Prev. 2011;20:1296-1302
57. Pampel FC, Krueger PM, Denney JT. Socioeconomic disparities in health behaviors. Annu Rev Sociol. 2010;36:349-370
58. Andrulis DP. Access to care is the centerpiece in the elimination of socioeconomic disparities in health. Ann Intern Med. 1998;129:412-416
59. Nguyen KH, Marshall L, Brown S, Neff L. State-specific prevalence of current cigarette smoking and smokeless tobacco use among adults—United States, 2014. MMWR Morb Mortal Wkly Rep. 2016;65:1045-1051
60. American Cancer Society. Cancer Prevention & Early Detection Facts & Figures 2017-2018. Atlanta: American Cancer Society; 2017
61. Singh GK, Jemal A. Socioeconomic and racial/ethnic disparities in cancer mortality, incidence, and survival in the United States, 1950-2014: over six decades of changing patterns and widening inequalities [serial online]. J Environ Public Health. 2017;2017:2819372
62. Davidoff AJ, Guy GP Jr, Hu X, et al. Changes in health insurance coverage associated with the Affordable Care Act among adults with and without a cancer history: population-based national estimates. Med Care. 2018;56:220-227
63. Fedewa SA, Goodman M, Flanders WD, et al. Elimination of cost-sharing and receipt of screening for colorectal and breast cancer. Cancer. 2015;121:3272-3280
64. Han X, Zang Xiong K, Kramer MR, Jemal A. The Affordable Care Act and cancer stage at diagnosis among young adults [serial online]. J Natl Cancer Inst. 2016;108:djw058
65. Han X, Yabroff KR, Robbins AS, Zheng Z, Jemal A. Dependent coverage and use of preventive care under the Affordable Care Act. N Engl J Med. 2014;371:2341-2342
66. Robbins AS, Han X, Ward EM, Simard EP, Zheng Z, Jemal A. Association between the Affordable Care Act dependent coverage expansion and cervical cancer stage and treatment in young women. JAMA. 2015;314:2189-2191
67. Jemal A, Lin CC, Davidoff AJ, Han X. Changes in insurance coverage and stage at diagnosis among nonelderly patients with cancer after the Affordable Care Act. J Clin Oncol. 2017;35:3906-3915
68. Chua KP, Sommers BD. Changes in health and medical spending among young adults under health reform. JAMA. 2014;311:2437-2439
69. Han X, Jemal A. The Affordable Care Act and cancer care for young adults. Cancer J. 2017;23:194-198